Author:
Bravo García-Morato M.,Padilla-Merlano B.,Nozal P.,Espiño M.,Juárez C.,Villar L.M.,López-Trascasa M.
Reference19 articles.
1. Guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS);Bird;Br J Haematol,2009
2. Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence;Rajkumar;Mayo Clin Proc,2010
3. Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma;Wadhera;Blood,2011
4. Trastornos de las células plasmáticas;Munshi,2012
5. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014